Press "Enter" to skip to content

New patent for Taro Pharms drug PLIAGLIS

1
Copyright © DrugPatentWatch. Originally published at New patent for Taro Pharms drug PLIAGLIS

Annual Drug Patent Expirations for PLIAGLIS
Annual Drug Patent Expirations for PLIAGLIS

Pliaglis is a drug marketed by Taro Pharms and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.

This drug has six patent family members in six countries.

The generic ingredient in PLIAGLIS is lidocaine; tetracaine. Two suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Taro Pharms drug PLIAGLIS

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!